HCW Biologics adjourns Special Meeting; warrants vote moved to June 15 Annual Meeting

HCW Biologics Inc.

Special Meeting on April 27 lacked quorum; no business conducted; adjourned to June 15.
Two proposals seek approval for warrants issued to Armistice Capital Master Fund Ltd.
Armistice invested $17.4M; warrants cover up to 5,497,702 shares at $0.6055 per share.
Company must seek stockholder approval every 60 days until obtained; incurring costs.
Record date for Annual Meeting is April 22, 2026; proxy statement filed April 28.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.